| News & Announcements | Coverage of Immune Globulin Intravenous (IVIG) and Subcutaneous (SCIG) for Measles Post-Exposure Prophylaxis in Commercial Members | | | | | | 1/16/2026 | | | |
| New Policies | Nipocalimab-aahu (Imaavy) | 08.02.43 | | 1/1/2026 | | | 1/2/2026 | This is a New Policy. | | |
| New Policies | Remote Electrical Neuromodulation for Migraines | 05.00.86 | | 1/1/2026 | | | 1/2/2026 | This is a New Policy. | | |
| New Policies | Leadless Pacemakers | 05.00.85 | | 1/1/2026 | | | 1/5/2026 | This is a New Policy. | | |
| Updated Policies | Telemedicine Services | 00.10.41q | 12/1/2025 10:00 AM | 1/1/2026 | | | 1/2/2026 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Ustekinumab for Intravenous Infusion | 08.00.82p | | 1/1/2026 | | | 1/2/2026 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Trastuzumab (Herceptin®) and Related Biosimilars, Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) | 08.00.33v | | 1/1/2026 | | | 1/2/2026 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Speech Therapy | 10.06.01o | | 1/1/2026 | | | 1/2/2026 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Preventive Care Services | 00.06.02ax | 10/3/2025 11:00 AM | 1/1/2026 | | | 1/2/2026 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Efbemalenograstim alfa-vuxw (Ryzneuta®), Eflapegrastim-xnst (Rolvedon™), Pegfilgrastim (Neulasta®) and Related Biosimilars | 08.01.32o | | 1/1/2026 | | | 1/2/2026 | Coverage and/or Reimbursement Position;Medical Necessity Criteria | | |
| Updated Policies | Eculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris®) for intravenous administration | 08.00.84m | | 1/1/2026 | | | 1/2/2026 | Medical Necessity Criteria | | |
| Updated Policies | Efgartigimod alfa - fcab (Vyvgart) | 08.01.84e | | 1/1/2026 | | | 1/2/2026 | Medical Necessity Criteria | | |
| Updated Policies | Coagulation Factors | 08.00.92ak | | 1/1/2026 | | | 1/2/2026 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Rituximab (Rituxan®) Infusion and Related Biosimilars, and Rituximab/Hyaluronidase Human for Subcutaneous Injection (Rituxan Hycela®) | 08.00.50af | | 1/1/2026 | | | 1/2/2026 | Coverage and/or Reimbursement Position;Medical Coding | | |
| Updated Policies | Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG) | 08.00.13am | | 1/1/2026 | | | 1/2/2026 | Coverage and/or Reimbursement Position;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists, VEGF Biosimilars, and Combination VEGF/Angiopoietin-2 (Ang-2) Inhibitors | 08.00.74ab | | 1/1/2026 | | | 1/2/2026 | Medical Necessity Criteria | | |
| Updated Policies | Radiation Therapy Services (AmeriHealth) | 09.00.56v | | 1/1/2026 | | | 1/5/2026 | Coverage and/or Reimbursement Position;Medical Coding | | |
| Updated Policies | Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) | 07.13.06q | | 10/1/2025 | | | 1/5/2026 | Medical Coding | | |
| Updated Policies | Peroral Endoscopic Myotomy (POEM) Procedures | 11.03.17a | | 1/5/2026 | | | 1/5/2026 | Medical Coding | | |
| Updated Policies | Musculoskeletal Services (AmeriHealth) | 00.01.66q | | 11/17/2025 | | | 1/6/2026 | Medical Necessity Criteria | | |
| Updated Policies | Durable Medical Equipment (DME) and Consumable Medical Supplies [AmeriHealth New Jersey] | 05.00.21ai | 10/10/2025 10:00 AM | 1/10/2026 | | | 1/9/2026 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Not Medically Necessary Services and Obsolete or Unreliable Diagnostic Tests | 00.01.24n | | 1/12/2026 | | | 1/12/2026 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG) | 08.00.13am | | 1/1/2026 | | | 1/13/2026 | Coverage and/or Reimbursement Position;Medical Coding;General Description, Guidelines, or Informational Update | | 1/13/2026 |
| Updated Policies | Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG) | 08.00.13am | | 1/1/2026 | | | 1/13/2026 | Coverage and/or Reimbursement Position;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Pembrolizumab (Keytruda®) | 08.01.63f | | 4/21/2025 | | | 1/23/2026 | Medical Necessity Criteria;Medical Coding | 1/23/2026 | |
| Reissue Policies | Acupuncture | 12.00.01i | | 1/1/2025 | 1/21/2026 | | 1/21/2026 | | | |
| Reissue Policies | Nucleoplasty | 11.15.19e | | 5/7/2014 | 1/21/2026 | | 1/21/2026 | | | |
| Reissue Policies | Evaluation and Treatment of Erectile Dysfunction (ED) | 11.11.01k | | 1/2/2024 | 1/21/2026 | | 1/21/2026 | | | |
| Reissue Policies | Cryosurgical Ablation of the Prostate Gland | 11.11.03d | | 4/6/2015 | 1/21/2026 | | 1/21/2026 | | | |
| Reissue Policies | Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for the Control of Incontinence | 11.17.04z | | 10/1/2024 | 1/21/2026 | | 1/21/2026 | | | |
| Coding Update | Intravenous Ketamine (Ketalar®) and Intranasal Esketamine (Spravato®) | 08.01.80e | | 1/1/2026 | | | 1/1/2026 | | | |
| Coding Update | Enzyme Replacement for the Treatment of Gaucher's Disease | 08.00.51m | | 1/2/2026 | | | 1/2/2026 | | | |
| Coding Update | Intra-Articular Injection of Hyaluronan for the Treatment of Osteoarthritis | 11.14.07z | | 1/2/2026 | | | 1/2/2026 | | | |
| Coding Update | Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound (AmeriHealth) | 11.02.27m | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Therapeutic Transcranial Magnetic Stimulation (TMS) | 07.03.22h | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Enzyme Replacement Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (e.g., elapegademase-lvlr [Revcovi]) | 08.01.26e | | 1/2/2026 | | | 1/2/2026 | | | |
| Coding Update | Intensity-Modulated Radiation Therapy (IMRT) (AmeriHealth Administrators) | 09.00.17r | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Reconstructive Breast Surgery and Post-Mastectomy Prostheses | 11.08.15ad | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Proton Beam Radiation Therapy (AmeriHealth Administrators) | 09.00.49o | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Brachytherapy and Accelerated Whole Breast Irradiation using Three-Dimensional Conformation Radiation Therapy | 09.00.10aa | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Tumor Treating Fields | 07.03.26b | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Routine/Non-routine Vaccines | 08.01.04ah | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Psychiatric Collaborative Care Management (CoCM) (AmeriHealth) | 00.01.70b | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Reimbursement for the Administration of Immunizations | 07.00.15o | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Gender-Affirming Interventions | 11.09.02s | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Treatments for Complex Regional Pain Syndrome (CRPS) | 08.00.57u | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Treatment of Varicose Veins of the Lower Extremities and Perforator Vein Incompetence | 11.02.01v | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | High-Technology Radiology Services (AmeriHealth) | 09.00.46au | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Percutaneous Image-Guided Lumbar Decompression (PILD) for Spinal Stenosis | 11.15.22e | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Musculoskeletal Services (AmeriHealth) | 00.01.66r | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Percutaneous Discectomy | 11.15.15h | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Spinal Discectomy (AmeriHealth Administrators) | 11.14.29i | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Ablation of Lung Tumors | 11.00.16k | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Bariatric Surgery | 11.03.02w | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Endovascular Stent Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal Lesions | 11.02.17j | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Photodynamic Therapy (PDT) Using Levulan® Kerastick® or Ameluz® (Aminolevulinic Acid HCl [ALA]) | 07.07.03o | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Low-Level Laser Therapy | 07.00.14i | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Wound Care: Skin Substitutes for the Treatment of Burns and Chronic, Non-Healing Wounds | 11.08.20ar | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD) | 11.03.11r | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for the Control of Incontinence | 11.17.04z | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH) | 11.17.06w | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Scar Revision | 11.08.25o | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Intravenous Infliximab and Related Biosimilars | 08.00.34x | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | linvoseltamab-gcpt (Lynozyfic™) | 08.02.47a | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Asparaginase Erwinia Chrysanthemi (recombinant)-rywn (Rylaze®) | 08.01.35k | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Telisotuzumab vedotin-tllv (Emrelis™) | 08.02.45a | | 1/1/2026 | | | 1/2/2026 | | | |
| Coding Update | Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility Campus | 00.10.39r | | 1/1/2026 | | | 1/6/2026 | | | |
| Coding Update | Musculoskeletal Services (AmeriHealth) | 00.01.66r | | 1/1/2026 | | | 1/6/2026 | | | |
| Coding Update | Care Management and Care Planning Services | 00.01.59p | | 1/1/2026 | | | 1/7/2026 | | | |
| Coding Update | Treatments for Complex Regional Pain Syndrome (CRPS) | 08.00.57u | | 1/1/2026 | | | 1/8/2026 | | | 1/8/2026 |
| Coding Update | Treatments for Complex Regional Pain Syndrome (CRPS) | 08.00.57u | | 1/1/2026 | | | 1/8/2026 | | | |
| Coding Update | Bundled Procedure Codes | 00.01.52z | | 1/1/2026 | | | 1/9/2026 | | | |
| Coding Update | Direct Access to Obstetrics/Gynecology (OB/GYN) Services | 00.09.01m | | 1/1/2026 | | | 1/9/2026 | | | |
| Coding Update | Modifier 25: Significant, Separately Identifiable Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional on the Same Day of the Procedure or Other Service | 03.00.06ad | | 1/1/2026 | | | 1/12/2026 | | | |
| Coding Update | Coverage of Anticancer Prescription Oral and Injectable Drugs and Biologics and Supportive Agents | 08.01.08v | | 1/1/2026 | | | 1/13/2026 | | | 1/13/2026 |
| Coding Update | Coverage of Anticancer Prescription Oral and Injectable Drugs and Biologics and Supportive Agents | 08.01.08v | | 1/1/2026 | | | 1/13/2026 | | | |
| Coding Update | New Jersey Health Maintenance Organization (HMO) and Health Maintenance Organization Point-of-Service (HMO-POS) Radiology Network Rules and Limited Circumstances | 00.01.55ab | | 1/1/2026 | | | 1/14/2026 | | | |
| Coding Update | Radiologic Guidance and/or Supervision and Interpretation of a Procedure | 00.10.36v | | 1/1/2026 | | | 1/22/2026 | | | |